09.01.2023Technical Assistant (BTA / MTA) (m/f/d) Leibniz-Institut für Immuntherapie (LIT), Regensburg
The LIT - Leibniz Institute for Immunotherapy (foundation under civil law) – is a biomedical research center focusing on translational immunology in the fields of cancer immunotherapy, transplant rejection and autoimmunity. The objective of the LIT is to develop efficient immune therapeutic strategies in these areas. The Schmidl lab is mainly interested in how our immune cells fight tumors, and investigates involved molecular and cellular mechanisms to improve the efficacy of immunotherapeutic applications.
The junior research group led by Christian Schmidl at the Leibniz Institute for Immunotherapy (LIT) is seeking an enthusiastic
Technical Assistant (BTA / MTA) (m/f/d)
part time (50%), limited to 2 years with possibility for extension
We look for a highly motivated colleague that is able to work independently, and who is eager to support a young lab. Being a team player as well as strong communication and organizational skills are necessary. Sufficient English skills to work in an international environment are mandatory. In addition to training in standard molecular and cellular methods such as western blot, PCR, cloning, cell culture, DNA and RNA isolation the applicant should bring experience in at least one of the following methods:
You will contribute to research projects investigating gene-regulatory mechanisms in primary immune cells in the tumor environment and stem cell transplantations. You will help to establish mouse models and use primary patient samples to contribute to the investigation of cellular and molecular mechanisms influencing the function of the immune system. In addition, you will receive training in next-generation-sequencing methods such as chromatin immunoprecipitation, chromatin accessibility mapping, and other sequencing library preparation approaches that will be used in the lab to decipher underlying (epi-)genetic mechanisms of immune regulation. As the technical assistant you will also be responsible for lab organizational tasks.
What we offer
Our lab offers the opportunity to work at the interface of immunology and cancer, which is one of the most exciting fields of recent biomedical research. We provide a dynamic and motivating working environment where you can foster your skills and get the opportunity to learn cutting-edge technologies such as next-generation-sequencing and CRISPR gene editing.
The remuneration is based on TV-L.
Moreover, the LIT advocates for the compatibility of family and career.
Disabled applicants (m/f/d) with equal qualifications will receive preferential treatment within the recruitment procedure. Please refer to your disability status already in your application.
Please note that expenses that may arise in the context of an eventual job interview cannot be reimbursed.
For more information, please contact Dr. Schmidl (christian.schmidl(at)ukr.de). We are looking forward to your detailed application. Please apply via our homepage www. rcii.de quoting the reference CS-2022-1.
Application deadline is January 19th, 2023.